Cart summary

You have no items in your shopping cart.

Dryocrassin ABBA

SKU: orb1220214

Description

Dryocrassin ABBA (Dryocrassin) is a flavonoid natural product derived from Dryopteris crassirhizoma, with antiviral and antibacterial activities. Dryocrassin ABBA exhibits antiviral activity against H5N1 avian influenza virus. Dryocrassin ABBA inhibits the coagulase activity of Staphylococcus aureus vWbp. Dryocrassin ABBA suppresses immunostimulatory function of dendritic cells and prolongs skin allograft survival.

Images & Validation

Key Properties

CAS Number12777-70-7
MW820.83
Purity>98% (HPLC)
FormulaC??H??O??
SMILESOC1=C(C(O)=C(C(CCC)=O)C(O)=C1CC(C(C(C(C)=O)=C(O)C2(C)C)=O)=C2O)CC(C(O)=C(C(CCC)=O)C(O)=C3CC(C(C(C(C)=O)=C(O)C4(C)C)=O)=C4O)=C3O
TargetInfluenza Virus
SolubilityIn Vitro: DMSO : 16.67 mg/mL (20.31 mM)

Bioactivity

In Vivo
Dryocrassin ABBA (Dryocrassin) (0-33 mg/kg; i. g. ; daily, 7 days from day 2 to day 8) exerts a significant dose-dependent antiviral effect in mice. Dryocrassin ABBA (100 mg/kg; s. c. ; every 12 h for 96 h) can reduce infection and prevent mice from contracting S. aureus pneumonia. Animal model: SPF BALB/C female mice inoculated intra-nasally with 104.5ELD50 H5N1 viruses in 100 μl saline. Dosage: 33, 18, and 12.5 mg/kg. Administration: Oral gavage, daily, 7 days from day 2 to day 8. Result: Significantly reduced mortality, prolonged survival rate, and improved survival time throughout the infection period. Increased body weight and reduced lung lesions and virus loads. Significantly increased MCP-1 and IL-10 while significantly decreased IL-12, IL-6, IFN-γ and TNF-α. Animal model: Eight-week-old C57BL/6J mice infected with 30 μL of S. aureus Newman (2 × 108 CFU/10 μL) by intranasal administration. Dosage: 100 mg/kg. Administration: Subcutaneous injection, every 12 h for 96 h. Result: Resulted a significant increase in survival.
In Vitro
Dryocrassin ABBA (Dryocrassin) inhibits the activity of S. aureus SrtA (sortase A) with an IC50 of 24.17 μM.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Dryocrassin ABBA [orb1302330]

    98.92%

    12777-70-7

    820.83

    C43H48O16

    1 mg, 5 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Dryocrassin ABBA (orb1220214)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

100 mg
200 mg
500 mg
5 mg
$ 720.00
10 mg
$ 1,200.00